American Enterprise Unit, 1150 17th Street, NW, Washington, DC 20036, USA [email protected]
Competing interests: SG has accepted speaking fees from branded pharmaceutical companies and does regulatory consulting work for Vertex Pharmaceuticals.
Provenance and peer review: Commissioned; not externally peer reviewed.
See EDITORIAL, p 308, NEWS, p 313, PERSONAL VIEW, p 359
The relationship between the drug industry, academia, healthcare professionals, and patients is widely held to be at an all time low, and it is in the interests of all parties to improve it. A report issued by the Royal College of Physicians this week gives 42 recommendations aimed at forging a more productive partnership with industry. Here we set out five views on what the ideal relationship between industry and prescribers and patients should be and what steps need to be taken to achieve it
TELL US YOUR VIEWS. Which view of the relationship between industry, doctors, and patients do you support? Vote on bmj.com
